Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Receivables - Other for 1 consecutive years, with $7.7 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Receivables - Other changed N/A year-over-year to $7.7 million, compared with a TTM value of $7.7 million through Dec 2022, changed N/A, and an annual FY2022 reading of $7.7 million, changed N/A over the prior year.
  • Receivables - Other was $7.7 million for Q4 2022 at Kiniksa Pharmaceuticals International.
  • Across five years, Receivables - Other topped out at $7.7 million in Q4 2022 and bottomed at $7.7 million in Q4 2022.